Millipore Sigma Vibrant Logo

AB19016 Anti-MMP-9 Antibody, Catalytic domain

View Products on Sigmaaldrich.com
AB19016
100 µg  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      Tableau de caractéristiques principal

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, M, RIHC, IP, WBRbPurifiedPolyclonal Antibody
      Description
      Catalogue NumberAB19016
      Replaces04-1150
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-MMP-9 Antibody, Catalytic domain
      Alternate Names
      • Gelatinase B
      • 92 kDa Type IV Collagenase
      Background InformationAll cells within tissues are surrounded by an extracellular matrix (ECM) giving the tissues shape and structure. The ECM is constantly being remodeled and constant communication is maintained between cells through this matrix. Secreted proteins, termed matrix metalloproteinases (MMPs), are involved in the modulation of cell matrix interactions. MMPs are Zn(2+) binding endopeptidases that degrade various components of the ECM.
      MMPs are enzymes implicated in normal and pathologic tissue remodeling processes, wound healing, angiogenesis, and tumor invasion. MMP9, also known as gelatinase B, is a secreted enzyme which degrades the interstitial collagens, types I, II, and III, and is produced by normal alveolar macrophages and granulocytes. The expression of MMP9 increases in Epstein-Barr virus infected lymphoma derived cell lines and may be of significance in typically invasive nasopharyngeal carcinomas.
      References
      Product Information
      FormatPurified
      HS Code3002 15 90
      Control
      • HL60 cell lysate, U937 cell lysate Lung.
      PresentationPurified rabbit polyclonal in buffer containing PBS, containing 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-MMP-9 Antibody, Catalytic domain is an antibody against MMP-9 for use in IH, IP & WB.
      Key Applications
      • Immunohistochemistry
      • Immunoprecipitation
      • Western Blotting
      Application NotesWestern Blot Analysis:
      1:1000 dilution of a previous lot was used.

      Immunoprecipitation:
      1:500 dilution from a previous lot was used. MMP-9 is constitutively produced by some tumor cell lines (i.e., HT1080, HL60, and U937), but not in most quiescent cells and tissues. The phorbol ester TPA stimulates production of MMP-9 in some cell types. MMP-9 levels in culture media (pg/mL) are often below the threshold of detection by standard Western Blotting. The enzyme can be concentrated from culture media by gelatin-agarose affinity chromatography (Goldberg, G.I. et al. J. Biol. Chem. 267, 4583-4591. 1992). This can prevent appearance of a spurious band of antibody binding in the vicinity of 68 kDa displayed by some concentrated media.
      Western blot: 1:2,000. Typically 98-95 kDa pro and 92-88kDa active forms are detected as well as breakdown products under fully reduced conditions. Under non-reduced conditions additional bands may be detected because of SDS-stable TIMP and other inhibitor complexes. CC069 is recommended as a positive control.

      Immunohistochemistry: 1:100 dilution from a previous lot was used in frozen acetone fixed tissues.

      Optimal working dilutions must be determined by end user.
      Biological Information
      ImmunogenE. coli-expressed active rat 92 kDa type IV collagenase (catalytic domain)
      EpitopeCatalytic domain
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityRecognizes rat MMP-9 pro and active forms. Antibody also reacts with mouse MMP-9 and human MMP-9, other species not tested. Exhibits no cross-reactivity with other MMP family members. The antibody was generated using E. coli-expressed active rat 92 kDa type IV collagenase (catalytic domain) as an immunogen.
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Species Reactivity NoteRat, Human, and Mouse. Reactivity with other species has not been confirmed.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryProteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. The enzyme encoded by this gene degrades type IV and V collagens. Studies in rhesus monkeys suggest that the enzyme is involved in IL-8-induced mobilization of hematopoietic progenitor cells from bone marrow, and murine studies suggest a role in tumor-associated tissue remodeling. [provided by RefSeq]
      Gene Symbol
      • MMP9
      • MMP-9
      • GELB
      • CLG4B
      • EC 3.4.24.35 [Contains: 67 kDa matrix metalloproteinase-9 82 kDa matrix metalloproteinase-9].
      Purification MethodProtein A Purfied
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: P14780 # May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly- -Leu bond.
      COFACTOR: Binds 2 zinc ions per subunit. & Binds 3 calcium ions per subunit.
      SIZE: 707 amino acids; 78427 Da
      SUBUNIT: Exists as monomer, disulfide-linked homodimer, and as a heterodimer with a 25 kDa protein. Macrophages and transformed cell lines produce only the monomeric form.
      TISSUE SPECIFICITY: Produced by normal alveolar macrophages and granulocytes.
      DOMAIN: SwissProt: P14780 The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.
      PTM: Processing of the precursor yields different active forms of 64, 67 and 82 kDa. Sequentially processing by MMP3 yields the 82 kDa matrix metalloproteinase-9.
      SIMILARITY: Belongs to the peptidase M10A family. & Contains 3 fibronectin type-II domains. & Contains 4 hemopexin-like domains.
      MISCELLANEOUS: In the arthritis patient this enzyme might contribute to the pathogenesis of joint destruction and might constitute a useful marker of disease status.
      Molecular Weight92 kDa
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceRoutinely evaluated by Western Blot on L6 lysates.

      Western Blot Analysis: 1:1000 dilution of this lot detected MMP-9 on 10 µg of L6 lysates.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      AB19016 04053252406942

      Documentation

      Required Licenses

      Title
      PRODUCTO REGULADO POR LA SECRETARÍA DE SALUD

      Anti-MMP-9 Antibody, Catalytic domain FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      Anti-MMP-9 Antibody, Catalytic domain Certificats d'analyse

      TitreNuméro de lot
      Anti-MMP-9, Catalytic domain AB19016
      Anti-MMP-9, Catalytic domain - 2464496 2464496
      Anti-MMP-9, Catalytic domain - 1957970 1957970
      Anti-MMP-9, Catalytic domain - 2004524 2004524
      Anti-MMP-9, Catalytic domain - 2037518 2037518
      Anti-MMP-9, Catalytic domain - 2075096 2075096
      Anti-MMP-9, Catalytic domain - 2165820 2165820
      Anti-MMP-9, Catalytic domain - 2219281 2219281
      Anti-MMP-9, Catalytic domain - 2279495 2279495
      Anti-MMP-9, Catalytic domain - 2365526 2365526

      Références bibliographiques

      Aperçu de la référence bibliographiqueApplicationEspèceNº PubMed
      Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells.
      Li, PC; Sheu, MJ; Ma, WF; Pan, CH; Sheu, JH; Wu, CH
      Marine drugs  13  3046-60  2015

      Afficher le résumé
      25988521 25988521
      Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration through the induction of RECK.
      Siddesha, JM; Valente, AJ; Sakamuri, SS; Gardner, JD; Delafontaine, P; Noda, M; Chandrasekar, B
      Journal of cellular physiology  229  845-55  2014

      Afficher le résumé
      Immunofluorescence24265116 24265116
      Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.
      Siddesha, JM; Valente, AJ; Yoshida, T; Sakamuri, SS; Delafontaine, P; Iba, H; Noda, M; Chandrasekar, B
      Cellular signalling  26  933-41  2014

      Afficher le résumé
      24447911 24447911
      Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in mice.
      Raghu, H; Jone, A; Cruz, C; Rewerts, CL; Frederick, MD; Thornton, S; Degen, JL; Flick, MJ
      Arthritis & rheumatology (Hoboken, N.J.)  66  1504-16  2014

      Afficher le résumé
      24574269 24574269
      Oxidative stress and extracellular matrices after hepatectomy and liver transplantation in rats.
      Hori, T; Uemoto, S; Chen, F; Gardner, LB; Baine, AM; Hata, T; Kogure, T; Nguyen, JH
      World journal of hepatology  6  72-84  2014

      Afficher le résumé
      24575166 24575166
      Targeting L1 cell adhesion molecule expression using liposome-encapsulated siRNA suppresses prostate cancer bone metastasis and growth.
      Sung, SY; Wu, IH; Chuang, PH; Petros, JA; Wu, HC; Zeng, HJ; Huang, WC; Chung, LW; Hsieh, CL
      Oncotarget  5  9911-29  2014

      Afficher le résumé
      25294816 25294816
      The novel IκB kinase β inhibitor IMD-0560 prevents bone invasion by oral squamous cell carcinoma.
      Tada, Y; Kokabu, S; Sugiyama, G; Nakatomi, C; Aoki, K; Fukushima, H; Osawa, K; Sugamori, Y; Ohya, K; Okamoto, M; Fujikawa, T; Itai, A; Matsuo, K; Watanabe, S; Jimi, E
      Oncotarget  5  12317-30  2014

      Afficher le résumé
      25373602 25373602
      Tetrahydrocurcumin protects against cadmium-induced hypertension, raised arterial stiffness and vascular remodeling in mice.
      Sangartit, W; Kukongviriyapan, U; Donpunha, W; Pakdeechote, P; Kukongviriyapan, V; Surawattanawan, P; Greenwald, SE
      PloS one  9  e114908  2014

      Afficher le résumé
      Immunohistochemistry25502771 25502771
      Keratin 79 identifies a novel population of migratory epithelial cells that initiates hair canal morphogenesis and regeneration.
      Veniaminova, NA; Vagnozzi, AN; Kopinke, D; Do, TT; Murtaugh, LC; Maillard, I; Dlugosz, AA; Reiter, JF; Wong, SY
      Development (Cambridge, England)  140  4870-80  2013

      Afficher le résumé
      24198274 24198274
      Increased aortic stiffness and attenuated lysyl oxidase activity in obesity.
      Chen, JY; Tsai, PJ; Tai, HC; Tsai, RL; Chang, YT; Wang, MC; Chiou, YW; Yeh, ML; Tang, MJ; Lam, CF; Shiesh, SC; Li, YH; Tsai, WC; Chou, CH; Lin, LJ; Wu, HL; Tsai, YS
      Arteriosclerosis, thrombosis, and vascular biology  33  839-46  2013

      Afficher le résumé
      Western BlottingMouse23413430 23413430

      Brochure

      Titre
      Advancing cancer research: From hallmarks & biomarkers to tumor microenvironment progression

      Produits & Applications associés

      Related Products

      Référence Description  
      AB6001 Anti-MMP-9 Antibody, NT Prix & Disponibilité
      MAB13415 Anti-MMP-9 Antibody, clone GE-213 Prix & Disponibilité
      MAB13458 Anti-MMP-9 Antibody, clone 9D4.2 Prix & Disponibilité
      MABT171 Anti-MMP-9 (Active) Antibody, clone 4A3 Prix & Disponibilité

      Catégories

      Life Science Research > Antibodies and Assays > Primary Antibodies